Canada - English - Health Canada

vita health products inc - choline bitartrate - tablet - 250mg - choline bitartrate 250mg - lipotropic agents

Canada - English - Health Canada

gahler enterprises ltd. - choline bitartrate - tablet - 250mg - choline bitartrate 250mg - lipotropic agents

Canada - English - Health Canada

health-wise nutrition inc. - choline bitartrate - tablet - 500mg - choline bitartrate 500mg - vitamin b complex

Canada - English - Health Canada

great earth companies, inc. - inositol; choline (choline bitartrate) - tablet - 250mg; 250mg - inositol 250mg; choline (choline bitartrate) 250mg - other nutritional agents

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - acetylcholine chloride, quantity: 10 mg/ml - diluent, not applicable - excipient ingredients: sodium acetate; magnesium chloride hexahydrate; potassium chloride; calcium chloride dihydrate; water for injections - miochol-e is used to obtain complete miosis of the iris in seconds after placement of the intraocular lens (iol) in cataract surgery; and in penetrating keratoplasty, iridectomy and other anterior segment surgery where rapid miosis may be required.

United States - English - NLM (National Library of Medicine)

sandoz inc - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine is contraindicated in persons with personal or familial history of malignant hyperthermia, skeletal muscle myopathies, and known hypersensitivity to the drug. it is also contraindicated in patients after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, because succinylcholine administered to such individuals may result in severe hyperkalemia which may result in cardiac arrest (see warnings ). the risk of hyperkalemia in these patients increases over time and usually peaks at 7 to 10 days after the injury. the risk is dependent on the extent and location of the injury. the precise time of onset and the duration of the risk period are not known.

United States - English - NLM (National Library of Medicine)

hospira, inc. - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine is contraindicated in persons with personal or familial history of malignant hyperthermia, skeletal muscle myopathies and known hypersensitivity to the drug. it is also contraindicated in patients after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, because succinylcholine administered to such individuals may result in severe hyperkalemia which may result in cardiac arrest (see warnings ). the risk of hyperkalemia in these patients increases over time and usually peaks at 7 to 10 days after the injury. the risk is dependent on the extent and location of the injury. the precise time of onset and the duration of the risk period are not known.

United States - English - NLM (National Library of Medicine)

eugia us llc - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride injection is indicated in adults and pediatric patients: - as an adjunct to general anesthesia - to facilitate tracheal intubation - to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine chloride is contraindicated: - in patients with skeletal muscle myopathies [see warnings and precautions (5.1)] - in patients with known hypersensitivity to succinylcholine chloride. severe anaphylactic reactions to succinylcholine chloride have been reported [see warnings and precautions (5.2)] - after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, which may result in severe hyperkalemia and cardiac arrest [see warnings and precautions (5.4)] - in patients with known or suspected genetic susceptibility to malignant hyperthermia [see warnings and precautions (5.5), clinical pharmacology (12.5)] risk summary available data from published literature from

Canada - English - Health Canada

methapharm inc - methacholine chloride - powder for solution - 100mg - methacholine chloride 100mg - other diagnostic agents

Canada - English - Health Canada

methapharm inc - methacholine chloride - powder for solution - 1280mg - methacholine chloride 1280mg - other diagnostic agents